Purpose: Oxazaphosphorines are metabolised by a variety of pathways, one of which leads to activation and the formation of alkylating compounds. However, the transport forms conveying activated oxazaphosphorines to the tumour cell have not been fully characterised. There is increasing recognition of the importance of the erythrocyte as a carrier of compounds in the circulation, and we have recently described higher concentrations of 4-hydroxycyclophosphamide within the erythrocyte compartment compared to plasma. We have now determined the concentrations of ifosfamide and seven of its metabolites in the plasma and erythrocytes of patients receiving a six-hour intravenous infusion of ifosfamide.
Introduction
Cyclophosphamide and its structural isomer ifosfamide are oxazaphosphorine alkylating agents used widely in the treatment of many solid tumours. They are prodrugs requiring activation by 4-hydroxylation within the cytochrome P450 system, with the ultimate formation of both active and inactive metabolites. In the case of ifosfamide, isophosphoramide mustard is the final alkylating species, but other metabolites are thought to be responsible for significant toxic effects, such as haemorrhagic cystitis [1] and neurotoxicity [2] .
The main site of formation of isophosphoramide mustard, and its predominant transport form within the circulation, is not certain. Two possibilities have been envisaged; firstly, the transport of 4-hydroxyifosfamide to tumour cells, which then convert this compound to isophosphoramide mustard, or secondly the formation of isophosphoramide mustard, primarily within the liver, but also within other tissues capable of activating ifosfamide, followed by transport within the circulation and direct penetration of tumour cells. The relative contribution of each of these mechanisms will influence the success of any attempt to administer isophosphoramide mustard itself as a chemotherapeutic agent, a potentially advantageous manoeuvre which should not lead to haemorrhagic cystitis or neurotoxicity.
Consequently, an improved knowledge of the processes of distribution of the oxazaphosphorines and their metabolites is needed. Blood consists of plasma and cells, and the vast majority of the cells are erythrocytes (approximately 45% of total blood volume). It is becoming clear that the erythrocyte is a significant carrier of substances in the circulation [3] , but there is little data concerning the distribution of oxazaphosphorines and their metabolites throughout whole blood in humans.
New developments in the bioanalysis of the oxazaphosphorines have provided methods for the separation and accurate measurement of many metabolites in plasma [4, 5] , and improved techniques of erythrocyte isolation have facilitated the study of the red cell compartment [6] . Recently, higher concentrations of 4-hydroxycyclophosphamide have been found within the erythrocyte compartment compared with plasma [7] , and we have now investigated the distribution of ifosfamide and seven of its metabolites in the plasma and red cells of patients receiving an infusion of ifosfamide. 
Patients and methods

Patients
Five patients were studied during their first course of chemotherapy, and three additionally through their second course of treatment. The protocol was approved by the local ethics committee. 3 g/m 2 ifosfamide was given as a six-hour infusion, with mesna as a uroprotector. Three patients also received mitomycin C and cisplatin, and one adriamycin.
Separation of red cells
Blood samples were taken at 0, 0.5, 1, 2, 4, 6, 7, 9, 12, 24 and 30 hours after commencing the ifosfamide infusion. The erythrocyte and plasma fractions were separated immediately using the MESED instrument [6] (P.O. Box 9, Fabre, Kelmis, Belgium), and stored at -20 °C. This technique allows the isolation of a known volume of almost pure red cell sediment, without disturbing the equilibrium normally present between the erythrocyte and plasma. The harvested erythrocytes were haemolysed totally with de-ionised water.
Determination of ifosfamide and its metabolites
The concentrations of these compounds in the plasma and erythrocyte fractions were measured using Gas Chromatography-Mass Spectrometry (GC/MS) [5] . Ifosfamide, isophosphoramide mustard, 2-dechloroethylifosfamide, 3-dechloroethylifosfamide, carboxyifosfamide and ketoifosfamide were isolated by solid phase C-18 extraction at pH 4. Derivatisation was performed in two stages by methylation of the acidic groups of carboxyifosfamide and isophosphoramide mustard, followed by trifluoroacetylation of unhindered phosphoramide groups. Analyses were then carried out using negative chemical ionisation by electron capture. The isolation of chloroethylamine and 1,3-oxazolidine-2-one was achieved by liquid extraction with ethyl acetate at pH 10. One step denvatisation using trifluoroacetic anhydride was used, and GC/MS performed in the electron impact ionisation mode. A small correction was made to account for trapped plasma between red cells in the sediment [6] .
Results
The mean concentration-time curves of ifosfamide and its metabolites, in plasma and erythrocytes, are shown in Figures 1 and 2 . All compounds entered the red cell compartment. Erythrocyte/plasma ratios at six Abbreviations: IF -ifosfamide; IPM -isophosphoramide mustard; CI -carboxyifosfamide; KI -ketoifosfamide; 2-DC -2-dechloroethylifosfamide; 3-DC -3-dechloroethylifosfamide; CEA -chloroethylamine; OXA -l,3-oxazolidine-2-one.
hours, corresponding to the end of the ifosfamide infusion, are given in Table 1 , and the mean values were greater than one for all compounds. Comparing erythrocytes and plasma, there were significantly higher concentrations of isophosphoramide mustard (two-tailed Mest; t -3.29; P = 0.0053), carboxyifosfamide (/ = 3.10; P = 0.0078) and ifosfamide (t = 2.74; P = 0.0161) in erythrocytes. Such differences were not detected for ketoifosfamide, chloroethylamine, l,3-oxazolidine-2-one, 2-dechloroethylifosfamide nor 3-dechloroethylifosfamide (P > 0.5). Considering all concentrations after six hours, significant differences between erythrocytes and plasma were maintained for isophosphoramide mustard (t = 4.49; P = 0.0005) and carboxyifosfamide (t -4.35; P -0.0007), but not for ifosfamide itself (t = 1.91; P -0.0773).
In terms of the area under the concentration-time curve (AUC), as calculated by the trapezoidal rule, the mean ratio of erythrocyte (AUC E ) to plasma (AUC P ) was also greater than unity in all cases ( Table 2) . The difference between AUC E and AUC P was most evident for carboxyifosfamide (t = 4.09; P = 0.0011), isophosphoramide mustard (t = 3.14; P -0.0072) and ifosfamide (r = 2.92; P -0.0112), but not significant for the other metabolites (P > 0.45).
Discussion
Previous work on the distribution of the oxazaphosphorines and their metabolites has focused on the identification of the circulating transport form of the activated compound, which in effect is responsible for conveying the cytotoxicity of these agents to the tumour cell. Some authors have favoured 4-hydroxycyclophosphamide, in the case of cyclophosphamide [8, 9] , and if correct, this compound should be detectable in the plasma. However, this has not always been the case, a situation explained by the instability of 4-hydroxycyclophosphamide and difficulties in its detection. Neverthe- less, some groups have identified persistent, albeit small, amounts of 4-hydroxycyclophosphamide in the plasma of mice [8] and humans [9] , proposing that low levels of 4-hydroxycyclophosphamide in plasma reflect intracellular trapping of this compound [8] .
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Other groups have argued that the mustard is the major transport form. Struck et al. [10] studied the activity of isophosphoramide mustard against murine tumours, found it comparable to ifosfamide, and postulated that isophosphoramide mustard acts by membrane alteration and/or non-DNA alkylation. The authors demonstrated that extracellularly delivered isophosphoramide mustard is an effective agent, with antitumour activity and selectivity in vivo comparable to ifosfamide and 4-hydroxyifosfamide.
Sladek has reviewed values of the ratio of phosphoramide mustard AUC to 4-hydroxycyclophosphamide AUC in the plasma of mice, rats and humans, following a dose of cyclophosphamide, and also the sensitivities of mice and human cell cultures to phosphoramide mustard and 4-hydroxycyclophosphamide [11] . He was able to calculate percentages of total cell kill hypothetically due to either circulating 4-hydroxycyclophosphamide or phosphoramide mustard, and found that the former compound was the circulating metabolite of major importance in the plasma, although the latter also made a contribution.
However, such studies have analysed plasma and have not considered the erythrocyte. We have investigated this compartment with a direct technique [6] , avoiding the need for red cell washing or calculation of red cell concentrations from those in plasma and whole blood; our results show that ifosfamide and its metabolites enter the erythrocyte compartment freely, and that isophosphoramide mustard and carboxyifosfamide are concentrated most significantly within this fraction. At the time of the peak erythrocyte isophosphoramide mustard concentration in one patient, 82% of the total amount of this compound in whole blood was associated with these cells, 13% was protein bound and 5% was present in plasma water; considering the whole blood AUC for isophosphoramide mustard, calculated from the haematocrit, 77% was found to reside within the erythrocyte. In addition to this high uptake by erythrocytes, the rate of loss from these cells is faster than from plasma ( Figure 1 ). As the concentration of isophosphoramide mustard in the erythrocyte fraction declines, there is no corresponding increase in chloroethylamine levels, indicating that the decline is not due to degradation. We have also found in vitro (data not shown), that there is a loose association of isophosphoramide mustard with the erythrocyte, and that this metabolite is released easily into blank plasma. Therefore erythrocyte mediated transport of isophosphoramide mustard within the circulation is significant, and transfer to tissues plausible. Following intravenous infusion, most of the ifosfamide is carried by erythrocytes and delivered to the liver. It is conceivable that a substantial amount of isophosphoramide mustard is transferred from the liver to its site of action associated with the red blood cell and in effect never enters the plasma, a situation similar to the transport of oxygen. It would be instructive to know whether an infusion of isophosphoramide mustard itself results in the same distribution pattern in whole blood, as the liver will no longer be a source of isophosphoramide mustard.
In early models of the interaction between blood and tissues, compounds have been described as entering tissues from the plasma water phase. However other models propose that inhibition of protein binding occurs on the capillary endothelium releasing protein bound compounds to the tissues [12] ; as a result tissue levels correspond more closely to the protein bound fraction than to the free fraction. This concept is equally important with regard to erythrocytes, as tissues on the other side of a capillary membrane may be more exposed to compounds accumulated .on these cells [13] , and the compounds may enter tissues just as easily from erythrocytes as from plasma water. Flow through capillaries is intermittent, and red cells are momentarily held in intimate contact with the capillary endothelium, allowing direct exchange between erythrocytes and endothelial cells [14] .
The structure and function of the tumour interstitium is significantly different from that of most normal tissues, and solid tumours can possess a special pattern of vascularisation [15] . For a solid neoplasm to survive, it must develop an adequate blood supply through the process of angiogenesis and then maintain the neovasculature so formed. In achieving this, endothelial cells in tumour vessels can proliferate more than twenty times faster than in normal vessels [16] . The action of cytotoxics on the capillary endothelium may contribute to their anti-tumour effect, as the disruption of a tumour capillary can lead to substantial tumour cell necrosis. Ifosfamide is used particularly in the treatment of solid tumours, and the intimate contact between the capillary endothelium and erythrocytes containing high concentrations of isophosphoramide mustard may be important. In a study often patients treated with cyclophosphamide, the median AUCE/AUCP ratios for 4-hydroxycyclophosphamide were 1.8 and 1.6 after oral and intravenous administration respectively [7] . Cyclophosphamide is also more commonly used in solid tumours than in the leukaemias.
The nature of the binding to erythrocytes is currently unclear. Uptake is not restricted to oxazaphosphorine metabolites, and is usually not as high. Many substances bind to erythrocytes [3] ; e.g. the concentration of bilirubin [17] and cortisol [18] increases in the erythrocyte compartment once albumin binding sites have been saturated, and red cells act as major transporters of acetaldehyde from the liver to tissues [19] .
Therefore it must be appreciated that transport by erythrocytes is the rule rather than the exception [3] . As many different compounds can be transported by red cells, usually weakly bound and with a shorter half-life on erythrocytes compared to plasma [3] , a nonspecific binding process such as adsorption to the cell surface comes to mind. The red cell surface area in a human adult is of the order of 3000 km 2 , about one million times larger than that of the total capillary endothelium. This ensures that the inner surface of the capillary membrane is in continuous equilibrium with the essentially fragmented membrane of the red cell compartment, which scrapes its surface. However, an association of compounds with proteins in the cell interior, such as that seen during adduct formation between nitrosamine metabolites and globins within haemoglobin [20] , cannot be excluded. As far as the transfer of compounds is concerned, the relevant factor is whether those associated with a red cell can be released to the capillary endothelium during passage through the capillary.
In conclusion, ifosfamide and its metabolites, especially isophosphoramide mustard and carboxyifosfamide, are sited primarily on the erythrocyte, which may have a role in the transfer of these compounds from the site of their formation to the tissues. Erythrocyte associated isophosphoramide mustard then acts as a vital transport form of activated ifosfamide.
